Tecnimede Group, established in the 1980s, is a pioneering Portuguese pharmaceutical company committed to advancing healthcare through cutting-edge pharmaceutical technology and high-quality treatment solutions. Since its inception, Tecnimede has grown into Portugal’s largest pharmaceutical company, with a presence in over 100 international markets and a reputation for excellence in research and innovation.

Our mission is to deliver value-added therapies that address complex healthcare needs, particularly in managing chronic diseases such as hypertension, diabetes, chronic pain, osteoporosis, and respiratory conditions. Tecnimede prioritizes patient-centered care, striving to improve quality of life through scientifically driven, effective, and accessible treatments.

At Tecnimede, innovation in pharmaceutical technology is at the heart of everything we do. Our robust investment in research and development supports initiatives that explore emerging technologies, including cell therapy, advanced drug delivery systems, and precision medicine. This commitment drives us to remain at the forefront of industry advancements and to develop solutions that meet the evolving needs of patients worldwide.

The Tecnimede Open Innovation Competition is an extension of our dedication to pioneering pharmaceutical technology. By fostering collaboration and encouraging innovative thinking, we invite bright minds to join us in creating transformative solutions that push the boundaries of healthcare. Together, we aim to shape a future where technology and medicine unite to address some of the world’s most pressing health challenges.